Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Relationship Between Clinical Status and Nerve Conduction Test Findings in Patients With Unilateral Hemiplegia

28 juli 2026 uppdaterad av: Baskent University

Prevalence of Peripheral Nerve Conduction Abnormalities and Their Association With Clinical Scores in Patients With Hemiplegia

Stroke-related hemiplegia may be accompanied by peripheral nerve conduction abnormalities, which may contribute to motor impairment and functional limitations. However, the frequency of these abnormalities and their relationship with clinical status have not been fully characterized. This single-center observational study aims to evaluate the frequency of peripheral nerve conduction abnormalities identified by nerve conduction studies in patients with unilateral hemiplegia and to examine their association with motor and functional clinical assessment scores. The findings may contribute to a better understanding of peripheral nerve involvement in stroke rehabilitation.

Studieöversikt

Status

Avslutad

Betingelser

Intervention / Behandling

Detaljerad beskrivning

This is a single-center observational study designed to evaluate peripheral nerve conduction abnormalities in patients with unilateral hemiplegia following stroke. Participants undergo standardized nerve conduction studies together with routine clinical assessments, including validated measures of motor recovery and functional status. The study aims to describe the frequency of peripheral nerve conduction abnormalities within the study population and to examine their association with clinical assessment scores. The results may improve the understanding of peripheral nerve involvement in patients with hemiplegia and provide information that may be useful for rehabilitation practice.

Studietyp

Observationell

Inskrivning (Faktisk)

72

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

  • Turkiet (Türkiye)
      • Adana, Turkiet (Türkiye), 01250
        • Başkent University Adana Dr. Turgut Noyan Application and Research Center

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Nej

Testmetod

Icke-sannolikhetsprov

Studera befolkning

Adults with unilateral hemiplegia secondary to ischemic or hemorrhagic stroke who were recruited from the Department of Physical Medicine and Rehabilitation at a single tertiary care center. All participants underwent standardized nerve conduction studies and clinical assessments according to the study protocol.

Beskrivning

Inclusion Criteria:

  • Adults (≥18 years of age).
  • Unilateral hemiplegia secondary to ischemic or hemorrhagic stroke, or intracranial hemorrhage.
  • Ability to undergo standardized nerve conduction studies and clinical assessments.
  • Provision of written informed consent.

Exclusion Criteria:

  • Bilateral hemiplegia.
  • Hemiplegia secondary to benign or malignant intracranial tumors.
  • Upper or lower extremity fracture, amputation, skin lesions preventing electrophysiological testing, or diagnosed peripheral vascular disease.
  • Concomitant neurological disorders that may affect motor function or peripheral nerve conduction (e.g., Parkinson's disease, multiple sclerosis, encephalitis).
  • Contraindications to nerve conduction studies (e.g., cardiac pacemaker or inability to safely undergo the examination).
  • Inability to cooperate with or tolerate nerve conduction studies.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

Kohorter och interventioner

Grupp / Kohort
Intervention / Behandling
Patients With Unilateral Post-Stroke Hemiplegia
Patients with unilateral post-stroke hemiplegia who underwent standardized nerve conduction studies and clinical assessments, including motor and functional outcome measures.
Diagnostiskt test: Nerve Conduction Study
Standardized motor and sensory nerve conduction studies were performed to evaluate peripheral nerve conduction abnormalities in patients with unilateral post-stroke hemiplegia. The test was used as a diagnostic assessment and was not part of a therapeutic intervention.
Andra namn:
  • NCS

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Association Between Peripheral Nerve Conduction Abnormalities and Clinical Assessment Scores
Tidsram: Baseline
To evaluate the association between peripheral nerve conduction abnormalities identified by standardized nerve conduction studies and motor and functional outcome measures in patients with unilateral hemiplegia secondary to ischemic or hemorrhagic stroke. Peripheral nerve conduction abnormalities identified by standardized nerve conduction studies will also be described.
Baseline

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Fugl-Meyer Assessment (FMA) Score (Upper and Lower Extremities)
Tidsram: Baseline
Association between peripheral nerve conduction abnormalities and motor impairment assessed using the Fugl-Meyer Assessment.
Baseline
Functional Independence Measure (FIM) Score
Tidsram: Baseline
Association between peripheral nerve conduction abnormalities and functional independence measured using the Functional Independence Measure.
Baseline
Timed Up and Go Test (TUG)
Tidsram: Baseline
Association between peripheral nerve conduction abnormalities and mobility performance assessed using the Timed Up and Go test.
Baseline
Tetrax Fall Index
Tidsram: At study enrollment (baseline)
The Fall Index was assessed using the Tetrax static posturography system. Higher scores indicate a greater estimated risk of falling.
At study enrollment (baseline)

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Baskent University

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

4 oktober 2024

Primärt slutförande (Faktisk)

20 maj 2026

Avslutad studie (Faktisk)

24 juni 2026

Studieregistreringsdatum

Först inskickad

29 juni 2026

Först inskickad som uppfyllde QC-kriterierna

29 juni 2026

Första postat (Faktisk)

6 juli 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

29 juli 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

28 juli 2026

Senast verifierad

1 juli 2026

Mer information

Termer relaterade till denna studie

Nyckelord

Ytterligare relevanta MeSH-villkor

Andra studie-ID-nummer

  • BASKENT UNIVERSITY KA24/315

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

OBESLUTSAM

IPD-planbeskrivning

A decision regarding the sharing of individual participant data has not yet been made. Data sharing will be considered after completion of the study and publication of the primary results, in accordance with institutional policies, ethical requirements, and applicable regulations.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera